United States · FDA National Drug Code directory
Dalbavancin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71839-144_02c586bb-801d-4e84-a155-b862b5758937
- Product NDC
- 71839-144
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Composition / generic term
- dalbavancin
- Labeler
- BE Pharmaceuticals Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20260612
- Source listing expiry
- 20271231
Source-listed ingredients
- DALBAVANCIN HYDROCHLORIDE — 500 mg/25mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL in 1 CARTON (71839-144-01) / 25 mL in 1 VIAL · 71839-144-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →